Cargando…

On barring the vascular gateway against severe COVID-19 disease

Detalles Bibliográficos
Autores principales:	Perdrizet, George, Hightower, Lawrence E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250245/ https://www.ncbi.nlm.nih.gov/pubmed/32458383 http://dx.doi.org/10.1007/s12192-020-01122-z

Ejemplares similares

COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
por: De Maio, Antonio, et al.
Publicado: (2020)

Introducing R. William (Bill) Currie as the new Editor-in-Chief of Cell Stress & Chaperones
por: Hightower, Lawrence E.
Publicado: (2021)

Is the Use of Nutritional Supplements in Dosage Forms a “Gateway” to Oral Substance Abuse?
por: Shirvani, Mahbubeh Ebrahimnegad, et al.
Publicado: (2015)

The underrecognized prothrombotic vascular disease of COVID‐19
por: Cohoon, Kevin P., et al.
Publicado: (2020)

Rare diseases' genetic newborn screening as the gateway to future genomic medicine: the Screen4Care EU-IMI project
por: Ferlini, Alessandra, et al.
Publicado: (2023)

Statins and other drugs: Facing COVID-19 as a vascular disease
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Can Covid-19 be iatrogenically auto-transmitted through combined oropharengeal and nasopharengeal swabs test with one Bar?
por: Alagozlu, Hakan
Publicado: (2022)

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

Impact of COVID-19 on the vascular interventionist
por: Mousa, Albeir Y, et al.
Publicado: (2020)

The impact of COVID-19 on vascular training
por: Mousa, Albeir Y., et al.
Publicado: (2020)

Intracranial hemorrhage related to brain vascular disease and COVID-19 containment: Where are the patients?
por: Bernat, A.-L., et al.
Publicado: (2020)

The Bar of Isis
Publicado: (1909)

Does androgen deprivation therapy protect against severe complications from COVID-19?
por: Patel, V.G., et al.
Publicado: (2020)

The Vascular Surgery COVID-19 Collaborative (VASCC)
por: Mouawad, Nicolas J., et al.
Publicado: (2020)

COVID-19: Precision Medicine and Vascular Endothelium
por: Tricarico, Gerardo, et al.
Publicado: (2021)

Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation
por: Parry, Arshed Hussain, et al.
Publicado: (2020)

Vascular surgery department adjustments in the era of the COVID-19 pandemic
por: Gouveia e Melo, Ryan, et al.
Publicado: (2020)

Regarding “Pulmonary Vascular Manifestations of COVID-19 Pneumonia”
por: Balestrieri, Antonella
Publicado: (2020)

The impact of COVID-19 on an Irish vascular unit's service
por: Connolly, Mary J., et al.
Publicado: (2021)

In reply—COVID-19: Precision Medicine and Vascular Endothelium
por: Cresci, Sharon, et al.
Publicado: (2021)

Is susceptibility to severe COVID‐19 disease an inborn error of metabolism?
por: Clayton, Peter T.
Publicado: (2020)

Governments and vaccination against COVID-19()
por: Javier Silva, L.A., et al.
Publicado: (2021)

Autoimmune diseases and vaccines against COVID-19. Decision-making in uncertain scenarios()
por: Calvo Elías, Alberto E., et al.
Publicado: (2022)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Histogram and Vertical Bar diagram: Often Misapprehended Concept
por: Lakshmanan, Mageshwaran
Publicado: (2014)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Are Patients With Autoimmune Disease at Greater Risk of Developing Severe COVID-19?
por: Lagadinou, Maria, et al.
Publicado: (2020)

Dementia is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2021)

Vascular Abnormalities as Part of Chest CT Findings in COVID-19
por: Qanadli, Salah D., et al.
Publicado: (2020)

Should people with chronic liver diseases be vaccinated against COVID-19?
por: Chen, Li-Ping, et al.
Publicado: (2021)

Enhancing Border Gateway Protocol Security Using Public Blockchain
por: Mastilak, Lukas, et al.
Publicado: (2020)

A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19
por: Zervos, Marcus, et al.
Publicado: (2020)

Diabetes and severity of COVID-19: What is the link?
por: Pitocco, D., et al.
Publicado: (2020)

Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues”
por: Ji, Dong, et al.
Publicado: (2021)

Vascular and Alzheimer Disease in Dementia
por: Strandberg, Timo E., et al.
Publicado: (2020)

Severe forms of COVID-19 among patients with chronic respiratory diseases: be attentive to the severity of the underlying respiratory impairment
por: Valentin, S., et al.
Publicado: (2022)

Preexisting prediabetes and the severity of COVID-19
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021)

Risk factors for severe COVID-19
por: Gupta, Harish
Publicado: (2023)

COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?
por: Caron, Benedicte, et al.
Publicado: (2020)

Liver Injury in Severe COVID-19 Disease: Need a Closer Look!
por: Jindal, Ankur
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a29dk1t2uh7opvdtge0n4qbosu